4
Changes in Ownership
RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-25-000413
EVP & Chief Financial Officer sold 3,770 shares at an average $21.38 ($80,615)
From the SEC's structured data for this filing
Trades in this filing
Schorno Dean L · EVP & Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-04 | Sale : show line 1 in the form | −2,036 | $20.92 | $42,595 | 58,969 | D |
| 2025-02-05 | Sale : show line 2 in the form | −1,734 | $21.93 | $38,020 | 57,235 | D |
| Open-market sales · 3,770 sh · avg $21.38 · $80,615 | ||||||
Loading xslF345X05/form4.xml…